The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Antiinflammatory Drugs Market Research Report 2025
Synopsis
Antiinflammatory Drugs are drug or substance that reduces inflammation (redness, swelling, and pain) in the body.
The global Antiinflammatory Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Antiinflammatory Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antiinflammatory Drugs.
Report Scope
The Antiinflammatory Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antiinflammatory Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antiinflammatory Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer, Inc
Abbvie, Inc
Johnson & Johnson
GlaxoSmithKline
Merck
Novartis
Almirall
Abbott
Zhejiang Jiuzhou Pharmaceutical
Boehringer Ingelheim
Jilin Huakang Pharmaceutical
Segment by Type
Steroidal Anti-Inflammatory Drug
Non-Steroidal Anti-Inflammatory Drug
Segment by Application
Drug Store
Hospital Pharmacies
Online
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antiinflammatory Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Antiinflammatory Drugs are drug or substance that reduces inflammation (redness, swelling, and pain) in the body.
The global Antiinflammatory Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Antiinflammatory Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antiinflammatory Drugs.
Report Scope
The Antiinflammatory Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antiinflammatory Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antiinflammatory Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer, Inc
Abbvie, Inc
Johnson & Johnson
GlaxoSmithKline
Merck
Novartis
Almirall
Abbott
Zhejiang Jiuzhou Pharmaceutical
Boehringer Ingelheim
Jilin Huakang Pharmaceutical
Segment by Type
Steroidal Anti-Inflammatory Drug
Non-Steroidal Anti-Inflammatory Drug
Segment by Application
Drug Store
Hospital Pharmacies
Online
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antiinflammatory Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antiinflammatory Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Steroidal Anti-Inflammatory Drug
1.2.3 Non-Steroidal Anti-Inflammatory Drug
1.3 Market by Application
1.3.1 Global Antiinflammatory Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Drug Store
1.3.3 Hospital Pharmacies
1.3.4 Online
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antiinflammatory Drugs Market Perspective (2019-2030)
2.2 Antiinflammatory Drugs Growth Trends by Region
2.2.1 Global Antiinflammatory Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Antiinflammatory Drugs Historic Market Size by Region (2019-2024)
2.2.3 Antiinflammatory Drugs Forecasted Market Size by Region (2025-2030)
2.3 Antiinflammatory Drugs Market Dynamics
2.3.1 Antiinflammatory Drugs Industry Trends
2.3.2 Antiinflammatory Drugs Market Drivers
2.3.3 Antiinflammatory Drugs Market Challenges
2.3.4 Antiinflammatory Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antiinflammatory Drugs Players by Revenue
3.1.1 Global Top Antiinflammatory Drugs Players by Revenue (2019-2024)
3.1.2 Global Antiinflammatory Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Antiinflammatory Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antiinflammatory Drugs Revenue
3.4 Global Antiinflammatory Drugs Market Concentration Ratio
3.4.1 Global Antiinflammatory Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antiinflammatory Drugs Revenue in 2023
3.5 Antiinflammatory Drugs Key Players Head office and Area Served
3.6 Key Players Antiinflammatory Drugs Product Solution and Service
3.7 Date of Enter into Antiinflammatory Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antiinflammatory Drugs Breakdown Data by Type
4.1 Global Antiinflammatory Drugs Historic Market Size by Type (2019-2024)
4.2 Global Antiinflammatory Drugs Forecasted Market Size by Type (2025-2030)
5 Antiinflammatory Drugs Breakdown Data by Application
5.1 Global Antiinflammatory Drugs Historic Market Size by Application (2019-2024)
5.2 Global Antiinflammatory Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Antiinflammatory Drugs Market Size (2019-2030)
6.2 North America Antiinflammatory Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Antiinflammatory Drugs Market Size by Country (2019-2024)
6.4 North America Antiinflammatory Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antiinflammatory Drugs Market Size (2019-2030)
7.2 Europe Antiinflammatory Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Antiinflammatory Drugs Market Size by Country (2019-2024)
7.4 Europe Antiinflammatory Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antiinflammatory Drugs Market Size (2019-2030)
8.2 Asia-Pacific Antiinflammatory Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Antiinflammatory Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Antiinflammatory Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antiinflammatory Drugs Market Size (2019-2030)
9.2 Latin America Antiinflammatory Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Antiinflammatory Drugs Market Size by Country (2019-2024)
9.4 Latin America Antiinflammatory Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antiinflammatory Drugs Market Size (2019-2030)
10.2 Middle East & Africa Antiinflammatory Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Antiinflammatory Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Antiinflammatory Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer, Inc
11.1.1 Pfizer, Inc Company Detail
11.1.2 Pfizer, Inc Business Overview
11.1.3 Pfizer, Inc Antiinflammatory Drugs Introduction
11.1.4 Pfizer, Inc Revenue in Antiinflammatory Drugs Business (2019-2024)
11.1.5 Pfizer, Inc Recent Development
11.2 Abbvie, Inc
11.2.1 Abbvie, Inc Company Detail
11.2.2 Abbvie, Inc Business Overview
11.2.3 Abbvie, Inc Antiinflammatory Drugs Introduction
11.2.4 Abbvie, Inc Revenue in Antiinflammatory Drugs Business (2019-2024)
11.2.5 Abbvie, Inc Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Detail
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Antiinflammatory Drugs Introduction
11.3.4 Johnson & Johnson Revenue in Antiinflammatory Drugs Business (2019-2024)
11.3.5 Johnson & Johnson Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Detail
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Antiinflammatory Drugs Introduction
11.4.4 GlaxoSmithKline Revenue in Antiinflammatory Drugs Business (2019-2024)
11.4.5 GlaxoSmithKline Recent Development
11.5 Merck
11.5.1 Merck Company Detail
11.5.2 Merck Business Overview
11.5.3 Merck Antiinflammatory Drugs Introduction
11.5.4 Merck Revenue in Antiinflammatory Drugs Business (2019-2024)
11.5.5 Merck Recent Development
11.6 Novartis
11.6.1 Novartis Company Detail
11.6.2 Novartis Business Overview
11.6.3 Novartis Antiinflammatory Drugs Introduction
11.6.4 Novartis Revenue in Antiinflammatory Drugs Business (2019-2024)
11.6.5 Novartis Recent Development
11.7 Almirall
11.7.1 Almirall Company Detail
11.7.2 Almirall Business Overview
11.7.3 Almirall Antiinflammatory Drugs Introduction
11.7.4 Almirall Revenue in Antiinflammatory Drugs Business (2019-2024)
11.7.5 Almirall Recent Development
11.8 Abbott
11.8.1 Abbott Company Detail
11.8.2 Abbott Business Overview
11.8.3 Abbott Antiinflammatory Drugs Introduction
11.8.4 Abbott Revenue in Antiinflammatory Drugs Business (2019-2024)
11.8.5 Abbott Recent Development
11.9 Zhejiang Jiuzhou Pharmaceutical
11.9.1 Zhejiang Jiuzhou Pharmaceutical Company Detail
11.9.2 Zhejiang Jiuzhou Pharmaceutical Business Overview
11.9.3 Zhejiang Jiuzhou Pharmaceutical Antiinflammatory Drugs Introduction
11.9.4 Zhejiang Jiuzhou Pharmaceutical Revenue in Antiinflammatory Drugs Business (2019-2024)
11.9.5 Zhejiang Jiuzhou Pharmaceutical Recent Development
11.10 Boehringer Ingelheim
11.10.1 Boehringer Ingelheim Company Detail
11.10.2 Boehringer Ingelheim Business Overview
11.10.3 Boehringer Ingelheim Antiinflammatory Drugs Introduction
11.10.4 Boehringer Ingelheim Revenue in Antiinflammatory Drugs Business (2019-2024)
11.10.5 Boehringer Ingelheim Recent Development
11.11 Jilin Huakang Pharmaceutical
11.11.1 Jilin Huakang Pharmaceutical Company Detail
11.11.2 Jilin Huakang Pharmaceutical Business Overview
11.11.3 Jilin Huakang Pharmaceutical Antiinflammatory Drugs Introduction
11.11.4 Jilin Huakang Pharmaceutical Revenue in Antiinflammatory Drugs Business (2019-2024)
11.11.5 Jilin Huakang Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
